| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.2545 |
| P698 | PubMed publication ID | 19334050 |
| P2093 | author name string | Susan Spencer | |
| Sarajane Ross | |||
| Simon Williams | |||
| Hartmut Koeppen | |||
| Jed Ross | |||
| Julie Sutcliffe | |||
| Maria Romero | |||
| Paul Polakis | |||
| Nicholas van Bruggen | |||
| Caroline Verbeke | |||
| Rich Erickson | |||
| Laura A Strickland | |||
| P2860 | cites work | CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells | Q28238822 |
| P433 | issue | 3 | |
| P921 | main subject | cell adhesion | Q187640 |
| adenocarcinoma | Q356033 | ||
| P304 | page(s) | 380-390 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. | |
| P478 | volume | 218 |
| Q40302231 | A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma. |
| Q38929320 | A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties |
| Q35583305 | An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors |
| Q38434946 | Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures |
| Q43852822 | CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo |
| Q34542396 | Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer |
| Q38125604 | Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis |
| Q41902817 | Conditions of tumor-associated antigens as a proper target for therapeutic antibodies against solid cancers |
| Q37973133 | Drugs in preclinical and early-stage clinical development for pancreatic cancer. |
| Q98386392 | Effect of CEACAM6 silencing on the biological behavior of human gallbladder cancer cells |
| Q41808426 | Effective combination gene therapy using CEACAM6-shRNA and the fusion suicide gene yCDglyTK for pancreatic carcinoma in vitro |
| Q38946429 | Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies |
| Q47158629 | EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner |
| Q39067515 | Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers. |
| Q92846263 | Gene Expression Changes Accompanying the Duodenal Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis |
| Q38788262 | High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer. |
| Q36044493 | Molecular targeting of CEACAM6 using antibody probes of different sizes |
| Q34428136 | Pharmacokinetics and biodistribution of a human monoclonal antibody to oxidized LDL in cynomolgus monkey using PET imaging |
| Q37698959 | Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studies |
| Q35152701 | Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study |
| Q37427937 | Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival. |
| Q39034542 | Quantitative proteomic analysis of sphere-forming stem-like oral cancer cells |
| Q28385210 | TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells |
| Q91672280 | Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6th antibody industrial symposium, June 25-26, 2018, Montpellier, France |
| Q93046345 | Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma |
| Q55483367 | Therapeutic antibodies for the treatment of pancreatic cancer. |
| Q26865516 | Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging |
| Q47432914 | Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. |
Search more.